Explore PMOS Research
Search 20,749 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active — and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies2,641–2,660 of 20,710
All studies
The Role of Curcumin in Polycystic Ovary Syndrome (PCOS): Evidence and Mechanisms
The Impact of Melatonin Supplementation on Various Aspects of Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis
Role of Myokine Decorin and Cholecalciferol as Therapeutic Targets in Polycystic Ovary Syndrome induced by estradiol valerate in a rat model.
The frequency of polycystic ovary syndrome in women with prediabetes compared with normoglycemic women
The effects of metformin and sitagliptin for polycystic ovary syndrome treatment are enhanced by combining them
OC57 - A multinational observational study on the clinical characteristics and treatments offered to women with polycystic ovary syndrome (PCOS)-related skin conditions presenting to specialist clinics
A literature review on the interplay of childhood trauma, PCOS, and attachment theory: implications for relationship functioning.
Feasibility of Continuous Glucose Monitor Use and Glucose Pattern Analysis in Females with Polycystic Ovary Syndrome
Pancreastatin inhibitor PSTi8 alleviates insulin resistance and ovarian dysfunction in a dehydroepiandrosterone–high-fat diet rat model of polycystic ovary syndrome
Trends and Future Projections of Polycystic Ovary Syndrome Burden Among Chinese Women (1990–2035).
Table 5_Role of follicle-stimulating hormone receptor polymorphism in predicting ovarian response to letrozole in women with polycystic ovary syndrome during ovulation induction.docx
Sweet Foods and Stasis Constitution of Chinese Medicine in Patients with Polycystic Ovary Syndrome
Hormone-Free vs Follicle-Stimulating Hormone-Primed Infertility Treatment of Women With Polycystic Ovary Syndrome Using Biphasic In Vitro Maturation: A Randomized Controlled Trial
Characteristics and Clinical Outcomes of Women with Polycystic Ovary Syndrome After Bariatric Surgery
Review for "Effects of estetrol/drospirenone versus ethinyl estradiol/drospirenone on glucose tolerance in women with polycystic ovary syndrome: A randomised controlled trial"
Distinguishing Polycystic Ovary Syndrome Phenotype D from Functional Hypothalamic Amenorrhea with Polycystic Ovarian Morphology: Clinical and Hormonal Insights from a Pilot Retrospective Study
Early Anti-Müllerian Hormone Levels in Adverse Pregnancy Outcomes in Women without Polycystic Ovary Syndrome
Evaluation of the effectiveness of complex therapy for generalised periodontitis in women of reproductive age with polycystic ovary syndrome
Empagliflozin Improves Follicular Development by Attenuating Oxidative Stress and Inflammation in a Mouse Model of Polycystic Ovary Syndrome
Table 1_Analyzing and evaluating the metabolic and endocrine characteristics between lean and obese patients with polycystic ovary syndrome: a systemic review and meta-analysis.docx